Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Administration of Sinovac SARS-CoV-2 and Quadrivalent Influenza Vaccines in Adults
NCT04801888Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Started Mar 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04801888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801888.